Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 1, Issue 2, pp. 134-143
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 10, 2013
- Revision received March 26, 2013
- Accepted March 30, 2013
- Published first May 20, 2013.
Article Versions
- Previous version (May 20, 2013 - 09:30).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Gian Luca Poli1,
- Claudia Bianchi1,
- Giorgio Virotta1,
- Anna Bettini1,
- Renzo Moretti1,
- Eveline Trachsel3,
- Giuliano Elia3,
- Leonardo Giovannoni2,
- Dario Neri4, and
- Andrea Bruno1
- Authors' Affiliations: 1Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; 2Philogen S.p.A., Siena, Italy; 3Philochem AG, Otelfingen; and 4Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
- Corresponding Authors:
Gian Luca Poli, Department of Medical Physics, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. Phone: 39-035-2674266; Fax: 39-035-2674798; E-mail: glpoli{at}hpg23.it; and Dario Neri, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland. Phone: 41-44-633-74-01; Fax: 41-44-633-13-58; E-mail: neri{at}pharma.ethz.ch
August 2013
Volume 1, Issue 2
Volume 1, Issue 2
Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
Jump to section
Advertisement